Here's what's in store this time: A bit of beautiful writing (really a meditation) on working with your hands. A possible explanation for why some objects become tainted, i.e. wrapped in the shadows of its origins, like "blood diamonds." Wealth work in the gig economy. And finally, another rapidly diminishing resource: sand.

In the most common type of pancreatic cancer, the abnormal cells contain highly fragmented mitochondria. New research suggests that they can serve as a novel target in the treatment of pancreatic cancer.

Do we act one way at work and another at home? Are ethics part of our personality or more situational? A new study offers some insight, at least based on our cheatin' heart.

The problem of high drug prices is multifaceted and complex. Referring to the pharmaceutical industry employing "crooks" might be good for some cheap applause, but it's demoralizing to the thousands of scientists who work in it. Senator Sanders should apologize.

Dr. Jeffrey Singer (pictured) is one of the brave physicians on the front line in the battle against anti-opioid madness. He graciously gave us permission to reprint his recent Cato Institute blog post. It speaks directly to the role of government in determining who gets what pain medicine, and how much. Dr. Singer addresses just this as he explains why Sen. Robert Portman (R-OH) went way off the deep end, proposing a national three-day limit on opioid prescriptions following surgery -- evidence be damned.

Patients with diabetes frequently have damaged nerves, resulting in neuropathy and a muted immune response. Scientists have found linkage of the two.

Just as the Roman roads helped the Visigoths run roughshod over Southern Europe, cancer’s invasion of distant organs exploits literal veins and arteries. This has implications for treatments and cures.

A new study tells us that since Florida passed a law restricting post-surgical opioid prescriptions, there are fewer post-surgical opioid prescriptions being written. This and other brilliance. Ripe for the picking.

Nutrition facts labeling is changing. Coming soon to a product near you, there will be a new information line telling you how much of the total sugars content is added. But will the new labels make any sense? Angela Dowden weighs in.

Surgery can be risky business. A new study looks at how complications can result in patient death. It doesn't add new information, but it was peer-reviewed. Replication is fine, but is it always necessary?